Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
3 drugs in development
By Therapeutic Area
top 3
R&D Momentum
85/100
Pipeline Velocity
70/100
Trial Completion Rate
97/100
Pipeline Concentration
28/100
Pipeline Freshness
84/100
Strategic Signals
Activity
Last 14 days
Ventrogluteal Intramuscular Injection in Individuals With High Body Mass Index: Ultrasound-Based Anatomical Measurements and Evaluation of Safe Intramuscular Placement of a 40 mm Needle
The Effect of Health Belief Model-Based Interventions Delivered Via Telenursing to Individuals Diagnosed With Hypertension on Hypertension Self-Efficacy and Quality of Life
A Prospective Longitudinal Observational Study of the Effects of Bariatric Surgery and Weight Loss on Lower Extremity Alignment and Mechanical Axis: Serial Evaluation of Hip-Knee-Ankle Alignment and Related Coronal Radiographic Parameters Before Surgery and at 3, 6, and 12 Months After Surgery in Patients With Morbid Obesity
A Prospective Longitudinal Observational Study of the Effects of Bariatric Surgery and Weight Loss on Spinopelvic Alignment and Global Sagittal Balance: Serial Evaluation of Spinal, Pelvic, and Spinopelvic Radiographic Parameters Before Surgery and at 3, 6, and 12 Months After Surgery in Patients With Morbid Obesity
Root-Level Diagnostic Sensitivity of the Femoral Stretch Test in Patients With L2, L3, or L4 Nerve Root Compression: A Prospective Observational Study
Evaluation of Surface Wear of Composites Used for Clear Aligner Attachments
Evaluation of Fluorescent Properties and Color Stability of 2 Different Composite Materials Used For Clear Aligner Attachments
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)